Organon & Co. (NYSE:OGN) went up by 1.09% from its latest closing price compared to the recent 1-year high of $38.75. The company’s stock price has collected -4.28% of loss in the last five trading sessions. Press Release reported on 11/22/21 that Organon To Present at the Evercore ISI 4th Annual HealthCONx Conference
Is It Worth Investing in Organon & Co. (NYSE :OGN) Right Now?
Organon & Co. (NYSE:OGN) scored a price-to-earnings ratio above its average ratio, recording 5.27 x from its present earnings ratio. Opinions of the stock are interesting as 3 analysts out of 8 who provided ratings for Organon & Co. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 5 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $40.14, which is $8.96 above the current price. OGN currently public float of 253.50M and currently shorts hold a 1.61% ratio of that float. Today, the average trading volume of OGN was 1.88M shares.
OGN’s Market Performance
OGN stocks went down by -4.28% for the week, with a monthly drop of -14.08% and a quarterly performance of -7.13%. The volatility ratio for the week stands at 2.92% while the volatility levels for the past 30 days are set at 3.00% for Organon & Co.. The simple moving average for the period of the last 20 days is -9.40% for OGN stocks with a simple moving average of -4.22% for the last 200 days.
Analysts’ Opinion of OGN
Many brokerage firms have already submitted their reports for OGN stocks, with Piper Sandler repeating the rating for OGN by listing it as a “Neutral.” The predicted price for OGN in the upcoming period, according to Piper Sandler is $35 based on the research report published on October 07th of the current year 2021.
BofA Securities, on the other hand, stated in their research note that they expect to see OGN reach a price target of $43. The rating they have provided for OGN stocks is “Buy” according to the report published on September 01st, 2021.
Citigroup gave a rating of “Buy” to OGN, setting the target price at $35 in the report published on July 22nd of the current year.
OGN Trading at -7.88% from the 50-Day Moving Average
After a stumble in the market that brought OGN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -18.61% of loss for the given period.
Volatility was left at 3.00%, however, over the last 30 days, the volatility rate increased by 2.92%, as shares sank -11.70% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -6.47% lower at present.
During the last 5 trading sessions, OGN fell by -4.28%, in comparison to the 20-day moving average, which settled at $34.60. In addition, Organon & Co. saw -5.14% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at OGN starting from Francisco Ma. Fatima, who purchase 3,000 shares at the price of $33.79 back on Aug 19. After this action, Francisco Ma. Fatima now owns 3,000 shares of Organon & Co., valued at $101,370 using the latest closing price.
Stock Fundamentals for OGN
Current profitability levels for the company are sitting at:
- +34.36 for the present operating margin
- +58.70 for the gross margin
The net margin for Organon & Co. stands at +26.68. The total capital return value is set at 39.89, while invested capital returns managed to touch 33.94.
Based on Organon & Co. (OGN), the company’s capital structure generated 22.62 points at debt to equity in total, while total debt to capital is 18.45. Total debt to assets is 12.51, with long-term debt to equity ratio resting at 1.29. Finally, the long-term debt to capital ratio is 1.06.
The receivables turnover for the company is 4.94 and the total asset turnover is 0.79. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.36.